PROTEOLYTIX Trademark

Trademark Overview


On Monday, August 24, 2020, a trademark application was filed for PROTEOLYTIX with the United States Patent and Trademark Office. The USPTO has given the PROTEOLYTIX trademark a serial number of 90132676. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, July 1, 2021. This trademark is owned by Proteolytix, LLC. The PROTEOLYTIX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development services in the field of antibodies, antibody technology; scientific research and development; custom design and development of chemical reagents, enzymes, antibodies and proteins; chemical engineering; behavioral analysis of chemicals; analysis of biochemical and biophysical data for proteins and antibodies; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; scientific research, namely, research, test and inspection in the field of therapeutic reagents for antibodies and proteins; consulting and research of product development in the field of biomedicine, genetics and pharmacodynamics; test and development of product development in the field of b...
proteolytix

General Information


Serial Number90132676
Word MarkPROTEOLYTIX
Filing DateMonday, August 24, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, July 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesresearch and development services in the field of antibodies, antibody technology; scientific research and development; custom design and development of chemical reagents, enzymes, antibodies and proteins; chemical engineering; behavioral analysis of chemicals; analysis of biochemical and biophysical data for proteins and antibodies; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; scientific research, namely, research, test and inspection in the field of therapeutic reagents for antibodies and proteins; consulting and research of product development in the field of biomedicine, genetics and pharmacodynamics; test and development of product development in the field of biomedicine, genetics and pharmacodynamics; development, testing, inspection and advice regarding the development, testing, and inspection of preparations and other pharmaceutical preparations in the field of biomedicine; research and development and consultation related thereto in the field of antibodies, antibody technology and proteins

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 25, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProteolytix, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKatonah, CA 10597

Trademark Events


Event DateEvent Description
Thursday, August 27, 2020NEW APPLICATION ENTERED
Friday, September 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 9, 2020ASSIGNED TO EXAMINER
Wednesday, February 12, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 12, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 12, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 1, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, December 11, 2020NON-FINAL ACTION WRITTEN
Friday, December 11, 2020NON-FINAL ACTION E-MAILED
Friday, December 11, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 1, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE